Tuesday 31 March 2020

Hammertoe Treatment Market -Research Report, industry Trends and Forecast to 2023

Hammertoe is a feet disorder wherein the feet permanently bends and is caused due to an imbalance in the muscles and the ligaments. It typically occurs while wearing shoes that are narrow or small-sized. In some cases, hammertoe occurs since birth in some individuals. 
According to the recently published report by Market Research Future (MRFR), the global hammertoe treatment market valuation is expected to reach USD 288.61 million by the end of 2023 from its 2018 valuation of USD 172.51 million. The market is forecasted to exhibit a CAGR of 10.8% during the forecast period of 2018 to 2023. 
The growth of the market, according to the report published by MRFR, is attributed to the rising prevalence of arthritis. 
Market Segmentation
The hammertoe market segmentation is classified into four key dynamics: type, end-user, treatment and diagnosis, and region.
By type, the market divides into flexible and rigid segments. It is reported that the rigid segment is anticipated to garner a CAGR of 11.2% during the forecast period. On the other hand, the flexible segment is calculated to register a CAGR of 8.3% during the forecast period.
By treatment, the market includes implant, surgery, and others. While in terms of diagnosis, the market includes physical examinations, x-rays, and others. Among these, the surgery segment is expected to lead the standings in terms of market during the assessment period. 
By end-users, the global market comprises hospitals, clinics, physiotherapy and orthopedic centers, and others. Herein, the hospital segment is anticipated to dominate the global market in the forthcoming years. 
By region, the hammertoe market covers North America, Europe, Asia Pacific, and the Middle East and Africa. 
Regional Analysis 
The regional market is led by North America in terms of market share in the global standings. The region is considered as one of the prime markets for foot and ankle surgery as well. The growth of the region can be attributed to the world-class healthcare infrastructure, rapid adoption of new products and treatments, and advanced medical facilities. With the availability of requisite products and skilled health professionals, and a high power of purchasing, the region is expected to expand in prolific manner in the near future. Moreover, some of the leading players functioning from this region are springing-in new innovation and developments in product to further ameliorate the growth of the market. 
Europe stands second in the global hammertoe market rankings. This is due to the advanced technology here and the fast-paced adoption of new devices. Western European nations like Germany, France, and the UK hold the maximum share of the overall region and contribute heavily to the growth of the regional market.
Asia Pacific is expected to be one of the fastest growing regions due to the fast-paced developing economy, changing healthcare industry, and increasing awareness concerning new products and treatments. Add to this, various profound initiatives have been undertaken by the government to enhance the health of the public. An expanding geriatric population coupled with cases of accidents are likely to propel the market growth in this region in the coming years.
Competitive Landscape
The global hammertoe market includes a number of key and prominent players like Stryker (U.S), BioPro (Michigan), Wright Medical Group N.V. (Memphis, TN), Arrowhead Medical Device Technologies LLC (Tennessee), Smith & Nephew (U.K), Extremity Medical LLC (U.S), Nextremity Solutions Inc. (U.S), and Zimmer Biomet Holdings (U.S).
March 12th, 2019, Nvision Biomedical Technologies’ Vector™ Hammertoe Correction System has been cleared for usage in the US by the Food and Drug Administration of America. It is the first ever ankle and foot implant that is made from advanced, biocompatible PEEK-OPTIMA™ HA Enhanced.
March 3rd, 2019, Centric Medical, a company specializing on developing surgical implants for treating distal extremity pathology, announced in a release the first clinical cases of the SATURN External Fixation System. The system is aimed at being used as a means for stabilizing bone segments for providing indications within the ankle and the foot. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Head Trauma market size Global Insights, Forecast 2020- 2023 - MRFR

Head Trauma Market – Overview
Rise in the number of trauma cases globally especially those of head trauma have prompted an increase in the demand for treatment. Market reports connected with the healthcare industry have been made accessible by Market Research Future who publishes reports on other sectors that have been recently put out along with a report on this industry. The market growth is foreseen to grow with a CAGR of 8.3% over the forecast period. The progress of the market is expected to benefit from the development of new technologies in the upcoming forecast period.
Segmental Analysis
The segmentation of the head trauma market size is segmented on the basis of types, diagnosis, treatment and end users. By types, the market is segmented into haemorrhage and hematoma. By diagnosis, the market is segmented into brain scans, physical examination, and CT scan. By treatment, the market segmentation comprises of anti-seizure drugs, medical treatment, and surgery. By end users, the market is segmented into research institutes and hospitals & clinics.
Detailed Regional Analysis 
The Americas region dominates the market due to the incidence of well-developed technology, growing patient population share with brain disorder, increasing health care spending, and budding government support for research & development. Additionally, intensified R&D activities and the focus of major companies are fuelling the market growth in this region. The European region has the next spot in the market due to the government support for research & development and accessibility of funds for research. This is projected to continue to drive the European market over the forecasted period. The Asia Pacific is showing the fastest growth due to the swiftly evolving healthcare technologies and high healthcare expenditure. Furthermore, the rising patient population in nations like India and South Korea are likely to fortify the market in the forecast period further. Conversely, the Middle East & Africa region controls the least stake in the market due to less accessibility of funds, inadequate medical facilities, and volatile political conditions in the African continent.
Segmentation
The global head trauma market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of the type, it is segmented into hematoma, and hemorrhage. On the basis of the diagnosis, it is segmented into physical examination, blood test, brain scans, and others. The brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG). Based on the treatment it is segmented into medical treatment, anti-seizure drugs, surgery, and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories, and others.
Key Players
Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

Hemophilia Treatment Market will Reflecting a CAGR of 6.18% by 2023

Market Overview
The global hemophilia market is forecasted to witness a steady growth of 6.10% during the forecast period between 2018 to 2023. The market valuation is slated to jump from USD 11,257.21 in 2018 to USD 16,059.18 by the end of the forecast period.
The report published by Market Research Future (MRFR) identifies that the prevalence of hemophilia will spring up the demand for hemophilia treatment market globally. The emergence of recombinant products for the treatment of hemophilia has blossomed the interest and demand for the market. The absence of a precise cure and the growing setbacks with the treatment of hemophilia has increased the need for discovering and coming up with new and effective solutions. Gene therapy is increasingly being explored and considered as a permanent solution for hemophilia and offers vast opportunities for the growth of the market.
However, the high cost associated with the treatment and the level of expenses required for consistent lab testing and imaging tests can go on to hamper the market growth of hemophilia treatment. 
Market Segmentation
The global hemophilia treatment market segmentation is based in terms of type, end-user, and treatment.
By type, the market is categorized into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment holds the largest share of the global market. The valuation of the segment is expected to reach USD 12.697.99 by the end of the forecast period, 2023. The calculated growth rate of the market annually has been projected to be 6.23% during the forecast period. 
By treatment, the market comprises of recombinant coagulation factor concentrates, plasma-derived coagulation factor concentrates, desmopressin, gene therapy, and antifibrinolytic agents. The recombinant coagulation factor concentrates is the largest market share holder with an expected CAGR of 7.01% during the review period. 
By end-users, the market includes hospitals & clinics, research organization, and others. Hospitals & clinics lead this segmentation of the market and is valued at USD 7594.66 in 2018 and is expected to grow the fastest over the forthcoming years. 
Regional Analysis
The regional segmentation of the hemophilia treatment market covers the following regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 
The Americas stand tall as the largest market share holder in the global geographical segmentation. This is due to the prevalence of the hemophilia disorder and the presence of a well-established healthcare sector. Growing expenditure in healthcare and increasing support for research and development activities are expected to aid the Americas region to maintain its leadership position. The North American market contributes more to the region than its southern counterpart. 
Europe holds the second biggest market share due to a parallel growth pattern like the Americas. Moreover, government support for R&D activities for advanced medical therapies for hemophilia is another important driver to the market growth in this region. 
Asia Pacific is expected to grow with the highest CAGR of 8.38% during the review period. The healthcare sector in this region is advancing at a rapid pace owing to the high disposable income in the region and expanding advanced medical facilities. The presence of a vast patient population base and a high healthcare expenditure is expected to positively impact the Asia Pacific market growth. 
Competitive Landscape
The global hemophilia treatment market includes various noteworthy players like Baxter, F.Hoffmann-La Roche Ltd, Octapharma, Swedish Orphan Biovitrum AB, Pfizer Inc, CSL Behring, Sanofi, Kedrion, Novo Nordisk A/S, Bayer AG, Grifols International S.A, and Shire.
Feb 19th, 2019, Novo Nordisk announced in a press release about the US FDA approval of N8-GP, turoctocog alfa pegol, to help treat children and adults with hemophilia A in the United States. The therapy will be under the brand name of Esperoct
Feb 7th, 2019, Roche announced its joining with the World Federation of Hemophilia (WFH) Humanitarian Aid Program. The program will see the company treating more than 1,500 people with Hemophilia A across various developing countries.
Read more @ https://www.marketresearchfuture.com/reports/hemophilia-treatment-market-5688
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: ,

Spirometry Market - Growth, Size, Trends

Overview:
The global Spirometry market is witnessing a significant rise in its revenues, mainly due to the rising occurrences of respiratory diseases such as asthma and COPD. Besides, the growing rate of diagnosis processes conducted for the detection of interstitial pulmonary fibrosis fosters the growth of the market. Moreover, the increasing exposure to risk factors and the ever-increasing population is driving a large share of the market.
Market Insights
According to the reports published by Market Research Future Reports, the global Spirometry Market size is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests.
Global Spirometry Market: Drivers & Trends
The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways.
More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.
Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come.
Segmental Overview
According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.
By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry.
By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.
By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring.
Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Outlook
Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.
While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.
Key Players
In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).
Posted by at No comments:

Sunday 29 March 2020

Current Trends and Future Demand of Global Connected Healthcare Market Outlook To 2025

Market Highlights
The global connected healthcare market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. Continuous increase in lifestyle disease has led to the development of personalized healthcare solutions is boosting the revenues per year.
Taste the market data and market information presented through more than 142 market data tables and figures spread over 152 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “The Global Connected Healthcare Market Research Report - Forecast to 2022”.

Global Connected Healthcare Market: 
Connected health is a new model for healthcare delivery which deliver healthcare services remotely. Connected healthcare creates an environment where patients are treated in the best location, by the best person, using the most relevant and efficient methods and cut down on waste and reduces system costs even though improving patient quality of life. It allows societies to maintain personalized healthcare in a climate of reducing resources and increasing demand. It enables genuine patient focus in the most efficient way possible.
The major participants of this market are Agamatrix, Inc. (US), Airstrip Technology (US), AliveCor Inc. (Australia), Allscripts (US), Athenahealth Inc. (US), Boston Scientific Corporation (US), Cerner (US), Koninklijke Philips N.V. (Netherlands), GE healthcare (UK), Qualcomm (US), Medtronics (Ireland) and others.
Market Research Analysis:

In recent years, due to the rise in connected healthcare applications has helped in driving the growth of the market. In the coming years, it is expected that the global connected healthcare market will advance with higher growth rate as compared to previous years.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Veterinary pain management Market Size is seeing an exponential growth by Key Players

Veterinary care is instrumental in alleviating the pain levels of companion and farm animals while tending to their injuries. Various drugs and treatments are administered to animals after considering the aftereffects as well as numerous risks. The global veterinary pain management market report by Market Research Future (MRFR) has compiled with a list of drivers, challenges, and opportunities being described in detail for comprehension of users.

Market Highlights:Veterinary Pain Management Market size is growing rapidly and pervasively mainly due to the spreading awareness towards animal care. People are generally compassionate towards their pets, and they are increasingly becoming aware of animal physiology and psychology and the pain they go through during sickness, injuries, recoveries and after effects of the diseases. Besides, factors such as the increasing number of pet owners and the strengthening bond between owners and their animal companions escalate the market on the global heights.
Acknowledging the rapid expansions, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global veterinary pain management market will reach significant growth heights by 2023 registering 8.2% CAGR during the review period (2018 – 2023).
Additional factors substantiating the market growth include the rising per capita income that is leading to increasing the pet adoptions and the trend of nuclear families. Increased awareness concerning animal cruelty is influencing people’s ideologies and knowledge about animals.
Moreover, developments in animal health medicines and vaccines, along with the increased medical treatments are fostering the market growth of veterinary pain management market. Increased R&D expenditure to bring innovations in the products, and development of better and effective veterinary pharmaceuticals and vaccines, etc. are contributing to the market growth.
Improving economic conditions worldwide foster market growth, enabling access to the quality of life, increasing consumers’ buying power, and availing cost-effective veterinary healthcare.
On the other hand, factors such as the lack of awareness and knowledge pertaining to the animal well-being and the rising cost of pet care, etc. are expected to impede the market growth. Also, unavailability of skilled doctors is a major restraint the market is confronting with.  Nevertheless, technological advancement, increasing number of ambulatory services coupled with the government and public organizations initiatives like PETA, working towards animal rights and liberation are expected to support market growth.
Veterinary Pain Management Market   - SegmentationsMRFR has segmented the analysis into seven key dynamics for better understanding: -
By Drug Type: Nonsteroidal Anti-Inflammatory Drugs, Opioids, Local Anesthetics, Α2-Adrenergic Agonists, Muscle Relaxants, Sedatives, and Corticosteroids among others.
By Devices: Laser Therapy Devices and Electromagnetic Therapy Devices among others.
By Route of Administration: Oral, Parenteral, and Topical among others. 
By Animal Type: Companion Animals, Livestock, Research Animals, Aquatic Animals, Zoo Animals, and Exotic Animals among others.
By Application: Joint Pain, Postoperative Pain, and Cancer among others.
By End-user: Veterinary Hospitals & Clinics, Research Institutes & Universities, and Laboratories among others.                                                                                                                  
By Regions:  Europe, North America, APAC and the Rest-of-the-World. Regional Analysis
North America, Asia Pacific, Europe, and Rest-of-the-World (RoW) are the regions being considered for the basis of the report. 
North America is estimated to hold the majority of the global veterinary pain management market due to rise in the adoption rate of pets in the U.S. and Canada. According to the survey by National Pet Owners, close to 68% of families owned household pets in the U.S. as of 2017. Other major drivers pushing the market expansion in the region include awareness of animal health, technically advanced devices, and preventive treatment facilities for companion animals. Investments in pet coverage schemes can bode well for the global veterinary pain management market in the forthcoming years.
Europe is the second biggest region for the market due to availability of advanced healthcare units and pet treatment clinics. Grading systems developing for assessing pain levels and doling out right advice are expected to drive regional market growth.
Competitive Outlook
Ceva Santé Animale, Elanco, Vetoquinol, Bayer, Assisi Animal Health, Zoetis, Merck Animal Health, Norbrook Laboratories, Boehringer Ingelheim, Dechra Pharmaceuticals, and Chanelle are major players of the global veterinary pain management market.
Industry/ Innovation/ Related News:
November 08, 2018 – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for large animal healthcare products, announced the launch of its rebranded product line - EQUISTRO®. The rebranding includes new packaging for products and others. All EQUISTRO products are now available in veterinary clinics and in retail stores that sell feed, farm supplies, horse tack, and equine products. The rebranding strategy helps to expand the products available for performance horses through Vetoquinol.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312

Posted by at No comments:
Labels: , , ,

Lab-on-a-Chip Market size - Global Industry Forecast to 2023

Market Highlights
The Lab-on-a-Chip Market size is forecasted to exhibit robust growth registering a CAGR of 10% during the forecast period. The global Lab-on-a-Chip device market is majorly driven by increasing application of lab on chip devices in the medical field in the diagnosis of various infectious diseases which eases sample handling and yields efficient results in a snap of time. Similarly, the use of lab-on-a-chip devices in research purposes is gaining traction due to easy portability, automated biochemical assays, and huge sample handling provision. Moreover, rising demand for miniature devices, advancing fabrication technology, research on biosensors and biomarkers, and economic feasibility of lab-on-a-chip devices are expected to spur the market growth. However, initial higher purchasing rate, as well as lack of awareness about the use of lab-on-a-chip devices in middle-income countries, are major restraints to the market growth.
Regional Analysis
Americas is the market leader and has an attractive market for lab on chip devices owing to increasing advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.  Additionally, factors such as increasing number of genomic and proteomics research labs government initiatives and funding for research, development of advanced medical treatment options, and rising demand for portable devices are likely to enhance the growth of Lab-on-a-Chip device market size in the American region. For instance, According to stats presented in the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years in the U.S. received an influenza vaccine. Due to the alarming rate of chronic as well as infectious diseases, use of lab-on-a-chip devices is accelerated due to its precision in diagnosis and multiple samples handling feature.
Europe is the second largest market and holds a healthy share in the global Lab-on-a-Chip device market due to major driving factors such as the flourishing medical device market, favorable government initiatives to promote life-science and clinical research, rising average per capita income of individuals. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D along with the ongoing legislative reforms is expected to have a positive impact on the Lab-on-a-Chip device market.
The Asia-Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool of chronic and infectious diseases, government initiatives of healthcare reform, increasing number of CROs and research projects on environmental issues. Furthermore, key medical device players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan,  and Australia thus, boosting the growth of Lab-on-a-Chip device market.
The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry and sound economic status of inhabitants. However, this area has the possibility to grow during the forecast period as due to increasing outbreak of new opportunistic pathogen associated diseases like Ebola, Zika Virus, and Hepatitis B which has attracted key players to set up their R&D centers in this region.
Industry Trends:
A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.
Segmentation:
The global LoC device market can be segmented by product, technology, application, and end-user. 
Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 
Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.
By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels: , , ,

Cardiac Implants Device Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin

Market Research Future (MRFR) has announced a new release on the Global Cardiac Implants Market. The report values the global cardiac implants market at USD 8.91 bn in 2017 and forecasts a steady rise at a 7.2% CAGR over the forecast period from 2018 to 2023. The global cardiac implants market is expected to rise to a valuation of USD 13.6 bn by 2023. 
Cardiac Implants Market Overview
Cardiac implants are specifically designed to monitor irregular heartbeats in people with heart rhythm disorders. Such disorders are mainly caused by problems associated with the heart’s electrical system, which signals the heart to pump blood throughout the body. Devices comprise implantable cardioverter defibrillators, pacemakers, implantable hemodynamic monitoring, cardiac resynchronization therapy, and implantable heart rhythm monitors, which are also referred to as loop recorders. The global cardiac implants market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 7.82%, surpassing a valuation of USD 38,054.3 million during the forecast period (2020-2023).
Global Cardiac Implants Market: Segmental Analysis
The cardiac implants device market has been segmented on the basis of device, indication, and end users.
By device, the market is segmented into prosthetic heart valve devices, coronary stents, and others.
By indication, the market is classified into heart failure, arrhythmias, and others.
Considering the end use segment, the market is segmented into cardiac care centers, hospitals, and others. Of these, the hospital segment is likely to gain prominence due to favorable reimbursement policies.
Cardiac Implants Market Regional Frontiers
Geographically, the cardiac implants market spans across America, Europe, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, America is predicted to command the largest market share, mainly due to the soaring incidences of cardiac diseases, coupled with the increased adoption rate of cardiac implantable electronic devices in the region. Moreover, increased demand for the pacemaker, especially in North America will contribute to the market’s growth.
The market in Europe will experience considerable growth owing to increased funding from the government for, healthcare, coupled with the rising initiatives by the insurance companies for heart patients.
The Asia Pacific will expand at the fastest rate during the foreseeable future. The growth can be credited to the rising geriatric population, increasing popularity of medical tourism, and changing lifestyle of the population. Surging preferences for technologically advanced products for cardiac rhythm management and increased concerns regarding healthcare for stroke prevention will encourage the regional market’s growth.
Industry Updates
August 2020: The U.S. FDA has recently approved a heart implant, which offers therapeutic stimulation to the patients suffering from advanced heart failure. The device named the Barostim Neo System is a cardiac neuromodulator, which helps to stimulate the baroreceptors of patients not suited for heart failure treatments such as cardiac resynchronization therapy.
Competitive Dashboard
The top players operating in the cardiac implants market include Amg International (Germany), Abbott (US), B. Braun Melsungen AG (Germany), Edwards Lifesciences Corporation (US), Boston Scientific Corporation (US), Biotronik (US), Medtronic Plc (US), LivaNova PLC (UK), Terumo Corporation (Japan), and SynCardia Systems, Inc. (Arizona).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Labels:

Friday 27 March 2020

Duloxetine Active Pharmaceutical Ingredients (API) Market size, Global Industry Growth and Demand

Global Duloxetine API Market” that contains the information from 2015 to 2023. The global duloxetine API market is expected to register at a CAGR 3.52% during the forecast period of 2018 to 2023
Market Research Future (MRFR) recognizes the following companies as the key players in the global duloxetine API market that includes Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Aurobindo Pharma (India), Lupin (India), Zydus Cadila (India), Eli Lilly and Company (United States), Shodhana Laboratories (India), Hetero (India), Apotex Inc. (Canada), Shionogi Inc. (US), and Zhejiang Huahai Pharmaceutical Co., Ltd (China)
Market Highlights
The global Duloxetine Active Pharmaceutical Ingredients Market size is expected to register a CAGR of 3.52% and is anticipated to reach USD 3,985.0 million by 2023. Active pharmaceutical ingredients (APIs) are used in the manufacturing of pharmaceutical dosage forms such as tablets and capsules. Duloxetine is a serotonin-norepinephrine reuptake inhibitor used in the treatment of depression and anxiety. Additionally, duloxetine API is used to help relieve neuropathic pain in people with diabetes or ongoing pain due to disease conditions such as arthritis, fibromyalgia, and chronic back pain.
The factors such as the rising prevalence of depression, growing penetration of generic drugs, growing cases of anxiety, the growing trend of outsourcing, strong drug pipeline, and increasing demand for newly developed small molecule drugs are expected to drive the market growth during the forecast period.
Segment analysis
The global duloxetine API market has been segmented into application. Based on application, the market has been segmented into major depressive disorder, generalized anxiety disorder, fibromyalgia, neuropathic pain, chronic musculoskeletal pain, and others. The chronic musculoskeletal pain accounted for a market value of USD 200.0 million in 2017.
Regional Analysis
Geographically, the Americas is expected to dominate the global duloxetine API market. In this region, North America is expected to dominate the market owing to the increasing incidence of chronic diseases such as psychological disorders, diabetes, increasing government focus on generic drugs, and technological advancements in the manufacturing processes of APIs. In Europe, the market growth is majorly due to the increasing pharmaceutical sector. Additionally, in Europe, countries such as the UK, Germany, and France have a higher demand for API and thereby drive the growth of the overall market. The Asia-Pacific market for duloxetine API is considered to be growing significantly due to the rising healthcare spending and a growing number of contract manufacturing organizations (CMOs). In this region, Japan accounted for a market share of 13.7% in 2017. Moreover, the Middle East and Africa accounted for the least share of the market. The low market share is due to the limited number of companies manufacturing duloxetine API.
Key Findings of the Study:
  • Global duloxetine API market is projected to reach USD 3,985.0 million by 2023 with 3.52% CAGR during the review period of 2018 to 2023.
  • Americas accounted for the largest share in the region due to the rapidly growing prevalence of anxiety and depression.
  • Some of the players operating in the duloxetine API market include Lupin, Teva Pharmaceutical Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Lupin, Zydus Cadila, among others.
This research report provides insights, on various levels of analysis such as industry analysis, market share analysis, leading market players, and their profiles. This report also helps in studying the target segments by providing views on emerging and high-growth segments and market conclusion. Together the market data comprises and discusses basic assessments on the competitive scenarios and strategies of the global duloxetine API market, including the high-growth regions and their political, economic, and technological environments. Furthermore, the project report also provides views over historical market values as well as, pricing and cost analysis of the same.
Posted by at No comments:
Labels: , ,

Emergency Department Information System (EDIS) Market 2023: Top Companies, CAGR Status, Trends, Size, Growth Factors Details for Business Development

Global Emergency Department Information System Market: Information by Component (Software, Services and Hardware), Delivery Mode (Software-as-a-Services (SaaS) and On-Premise EDIS), Application (Clinical Functionality, Patient Entry, Tracking and Triage, Department-Centered Tracking, Clinical Documentation, Computer Provider Order Entry (CPOE), Result Reporting and Discharge Management Region & Administrative Functions), End User, (Large Hospitals, Medium-Sized Hospitals and Small Hospitals) - Forecast till 2023
Market Synopsis:
As per the report published by Market Research Future (MRFR), the global Emergency Department Information System (EDIS) Market is set to thrive exponentially at a CAGR of 15.10% during the forecast period 2017 to 2023. These systems are designed to enhance the quality of emergency services by taking care of functions such as clinical documentation, patient entry, patient and resource tracking, etc. It is presumed to gain popularity globally in the foreseeable future owing to the rapid developments in the healthcare sector.
One of the key factors responsible for dictating the future trajectory of the global emergency department information system market is the increasing geriatric population. Elderly people are always at a higher risk of developing diseases, and the increase in their population has necessitated the adoption of technologically advanced systems in the healthcare sector. This, in turn, has paved the way for emergency department information systems into the hospitals and clinics.
Other factors that are likely to complement the proliferation of the emergency department information system market include rising healthcare expenditure, growing patient pool, increasing need for advanced treatments, etc. In addition, the growing number of hospitals and clinics in the developing regions resonate strong potential for growth in the upcoming years.

Regional Analysis:
The global emergency department information system market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas had the largest share of the market in 2016 and is poised to grow significantly over the next couple of years. The factors that are favoring the expansion of the emergency department information system in the region include consolidation of key players, accelerated adoption of novel technologies, technological innovations, etc.
Asia Pacific is set to strike a high CAGR of 15.71% during the forecast period. It is estimated to emerge as the fastest growing regional market towards the end of the assessment period. Factors such as rapid healthcare developments, strong economic growth rate, increasing count of healthcare providers, etc. are expected to augment the emergency department information system market in the region.
Europe is a significant growth pocket positioned at the second position in the marketplace. Meanwhile, the Middle East & Africa is anticipated to account for the least share of the global market. The slow growth rate is attributable to the slow economic development and low income.
Market Segmentation:
On the basis of component, the global emergency department information system market has been segmented into software, services, and hardware. Furthermore, the software is sub-segmented into Best-of-Breed solutions and enterprise solutions.
On the basis of delivery mode, the emergency department information system market has been segmented into Software-as-a-Service and on-premise.
On the basis of the application, the global emergency department information system market has been segmented into clinical functionalities and administrative functionalities.
On the basis of the end users, the emergency department information system market has been segmented into large hospitals, medium-sized hospitals, and small hospitals.
Competitive Dashboard:
Some of the key players profiled in the report are Allscripts, Cerner Corporation, Mckesson Corporation, Healthland, Inc, Epic Systems, Evident, Logibec Canada, T-System Inc, Siemens Healthcare, EPOWERdoc, Inc, Medical Information Technology, Inc, Unitedhealth Group, Inc, veEDIS Clinical Systems LLC, Medhost Inc, and Wellsoft.
Industry News:
In August 2018, Allscripts Healthcare Solutions, Inc., a healthcare service provider, has achieved full accreditation for Allscripts PayerpathTM with the Healthcare Network Accreditation Program (HNAP).
In July 2018, Virginia has launched an Emergency Department Care Coordination Program where all of its emergency departments are electronically linked for improved care and trimmed costs.
In January 2019, the Centers for Medicare and Medicaid Services (CMS), a federal agency within the United States Department of Health and Human Services has initiated posting prices of healthcare services online.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels: ,

Medication Management Market: Competitive Landscape and Recent Industry Development Analysis 2018-2023

Medication management is an approach to understand the purpose of the medications and its timely administration in the correct manner. Adherence to a medication regimen is vital especially for geriatrics and patients with multiple chronic conditions. Failing to comply with a medication regimen is often cited as a paramount reason why patients are readmitted in the hospital following discharge. 
In such scenarios, medication management services have been proving to be effective providing medication reconciliation, medication therapy management, patient/family education on medications and medication set-up simulations for the patient. Many home care providers have also started to make in-home medication management a core component of their operations.
For many aging populaces, relinquishing medication management services to a third party is one of the easier options. And it’s becoming a market differentiator among seniors looking for reliable, competent and service-minded companies to manage one of their most critical medical issues. 
Also, for the patients suffering from chronic illnesses who usually have to administer and monitor 10-12 medications per day, resorting to smart medication management systems which promote their wellbeing becomes useful. 
As a result, the uptake of medication management is growing which, in turn, is increasing the size of the global medication management market. Moreover, the recent trend of prescription medicine is escalating the market on the global platform. 
Considering the colossal growth, the market perceives currently; Market Research Future (MRFR), in its recently published study report asserts that the global medication management market will grow exponentially by 2023, registering approximately 13.4% CAGR throughout the forecast period (2018 – 2023).
Additional factors helping the market to boost further are the ever-increasing population, geriatric populaces, and increased occurrence of chronic diseases which are growing the need for the medication management solutions.
Advancements in IT technology and increasing uptake of healthcare IT for efficient management are expected to increase the size of the market. Furthermore, the rising government supports and the need for curtail healthcare costs without compromising the quality of care are some of the factors impacting the growth of the market, positively. 
On the other hand, factors such as high software implementation and service maintenance costs are impeding the growth of the market. Nevertheless, the advantages that medication management offers allowing the consolidation of all expenses which consequently saves the further cost of patient care is expected to act as a major tailwind supporting the growth of the market. 
 for care management solutions.  Moreover, the increasing healthcare expenditures are escalating the market on the global platform, increasing the need to curtail cost without compromising the quality of care.

Global Medication Management Market    – Segmentation
For ease of understanding, the MRFR analysis has been segmented into five key dynamics: -
By Systems                          : Computerized Physician Order Entry Systems, Administration Software, Clinical Decision Support Systems, Inventory Management Systems, Automated Dispensing Systems, and Assurance Systems among others. 
By Services                          : Point-of-Care Verification Services and Adverse Drug Effects (ADE) Surveillance Services among others. 
By Mode of Delivery        : Web-based Solutions, On-premise Solutions, and Cloud-based Solutions among others.
By End-user                         : Hospitals and Pharmacies among others.
By Regions                          : North America, Europe, Asia Pacific, and the Rest-of-the-World.

Medication Management Market – Regional Analysis
The North American region, heading with the presence of numerous key players is estimated to retain its dominance over the global medication management market. This region accounts for the best of the medical facilities around the world, and so is the higher rate of patients which along with the robust economy and high healthcare expenditure drive the medication management market in the region. 
Furthermore, the increasing number of polypharmacy, hospitals, and ambulatory centers alongside the well-developed technology drive the market growth in the region, meeting the higher demand of a vast patient population. 
The medication management market in the European region accounts for the next-largest market share, globally. Factors allowing the market to substantiate include the increasing demand for management software & platforms, strong government support, and availability of funds among others. Western European region backed by the presence of well-developed economies such as the U.K., Germany, and France holds a significant share in the regional market. Indeed, the resurging economy is playing a vital role in the growth of the market, making the high cost of medication affordable and increasing per capita income in this region. 
The Asia Pacific medication management market has emerged as a profitable market, globally. Factors such as the rapidly proliferating healthcare sector that is led by the improving economy, the increasing number of players, increasing government’s support and foreign investments, and vast technological advancements are impacting the regional market, positively. Additionally, the growing number of patients suffering from chronic diseases alongside the increasing per capita healthcare expenditure provide impetus to the growth of the market.
The Asia Pacific together accounts for over 41% of the global population, and most of the APAC countries are in the developing phase which leads to providing immense opportunities for the market players. Larger countries such as China and India backed by the densely populated area are considered as the biggest market for the Medication Management products in the region.

Global Medication Management Market – Competitive Analysis 
The medication management market appears fiercely competitive with the presence of several large and small players. The key strategies traced from the analysis of recent market developments include agreement & partnership, product launch, acquisition, and expansion.  International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional players to compete with them.
Major Players:
Key players leading the global medication management market include Mckesson Corporation, Allscripts Healthcare 0Electric Company, Medical Information Technology, Inc., Optum Inc., Omnicell, Inc., QuadraMed Affinity Corporation, and Siemens Ltd among others.
Industry, Innovation & Related News 
March 06, 2019 ---- BrightSpring Health Services (the US) a leading provider of comprehensive home and community-based health services announced its merge with the PharMerica (the US), a pharmacy powerhouse to position itself to lead the medication management, potentially.
BrightSpring hopes to effectively address medication needs while also providing caregiver services by providing its clients the right medications suiting their ailments in a timely and reliable manner and then helping to make sure they do so consistently. 
The merging deal will give BrightSpring a footprint with difficult-to-top proximity to the patients and clients it serves including behavioral health and specialty populations, along with older adults. KKR an affiliate of Walgreens Boots Alliance Inc. and a global investment firm had recently acquired BrightSpring (formerly ResCare) as part of the deal. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com 


Posted by at No comments:
Labels: ,
Subscribe to: Posts (Atom)